Chairs: Annika Bergquist (Annika.email@example.com) and Kristina Ringe (Ringe.Kristina@mh-hannover.de)
Magnetic resonance imaging (MRI) plays a central role in the diagnosis of PSC and holds significant promise as a method to predict disease outcomes. Consequently, the MRI PSC Working Group was established to provide a collaborative network that seeks to foster discovery and innovation regarding the application of MRI-based technologies in the diagnosis of PSC and detection of disease related complications.
The interdisciplinary collaboration between radiologists and hepatologists has been a prerequisite for the successful work in the group and results.
Ongoing projects (Feb. 2021)
MRI surveillance for CCA in PSC
Annika Bergquist, Stockholm
MRI CCA localization – database
Henrike Lenzen & Kristina Ringe, Hannover
Standardized MRI reporting system for patients with PSC”? and definition of the term dominant stricture” using MRI
Sudhakar Venkatesh & John Eaton, Rochester
Christoph Schramm and
Anne Ernst, Hamburg.
Next host for MRI meeting is Oslo when the pandemic is over – TBA
Minutes from meetings
IPSCSG – Publications
- Ringe KI, Grigoriadis A, Halibasic E, Wacker F, Manns MP, Schramm C, et al. Recommendations on the Use of Magnetic Resonance Imaging for Collaborative Multicenter Studies in Primary Sclerosing Cholangitis. Hepatology. 2019;69(3):1358-9.
- Schramm C, Eaton J, Ringe KI, Venkatesh S, Yamamura J, IPSCSG MRIwgot. Recommendations on the use of magnetic resonance imaging in PSC-A position statement from the International PSC Study Group. Hepatology. 2017;66(5):1675-88.